Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

27.3%

3 terminated/withdrawn out of 11 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
5(71.4%)
Phase 2
1(14.3%)
Phase 4
1(14.3%)
7Total
N/A(5)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials
NCT04540510Not ApplicableTerminated

OPEP Devices in Acute Inpatient Treatment of Pneumonia

Role: lead

NCT04655443Terminated

Risk Factors That Contribute to the Maintenance of Sinus Rhythm

Role: lead

NCT03870685Phase 4Unknown

Surgical Site Infiltration of Exparel vs TAP Block With Exparel in Patients Undergoing Laparotomy Via Midline Incision

Role: lead

NCT02908841Not ApplicableCompleted

Surgicel Snow in Gynecological Surgery

Role: lead

NCT04687449Not ApplicableUnknown

Curcumin in Management of Chronic Obstructive Pulmonary Disease

Role: lead

NCT02916433Phase 2Completed

Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients

Role: lead

NCT04294303Not ApplicableCompleted

Use of Telemonitoring System in Heart Failure Patients

Role: lead

NCT03930875Completed

Aspirin Resistance in OSA Patients

Role: lead

NCT02359734Completed

A National Study of Intravenous Medication Errors

Role: collaborator

NCT02091193Completed

Effects of Krill Oil on Endothelial Function in Patients With Type 2 Diabetes Mellitus

Role: lead

NCT02323711Not ApplicableWithdrawn

Dressing Versus Glue (2-Octyl Cyanoacrylate) for Coverage of the Skin Incision After Closure During Cesarean Delivery

Role: lead

All 11 trials loaded